Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Tsuguo Iwatani"'
Autor:
Masato Takahashi, Yuichiro Kikawa, Kosuke Kashiwabara, Naruto Taira, Tsuguo Iwatani, Kojiro Shimozuma, Shoichiro Ohtani, Tetsuhiro Yoshinami, Junichiro Watanabe, Masahiro Kashiwaba, Ken-ichi Watanabe, Masahiro Kitada, Koichi Sakaguchi, Yuko Tanabe, Tomohiko Aihara, Hirofumi Mukai
Publikováno v:
EClinicalMedicine, Vol 74, Iss , Pp 102715- (2024)
Summary: Background: Eribulin prolongs overall survival (OS) of patients with human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (MBC), particularly in later chemotherapy (ChT) treatment. However, the health-related qua
Externí odkaz:
https://doaj.org/article/1723e209a4034dd0b0e8a27d67cd3241
Autor:
Megumi Uchida, Toshiaki A Furukawa, Takuhiro Yamaguchi, Fuminobu Imai, Kanae Momino, Fujika Katsuki, Naomi Sakurai, Tempei Miyaji, Masaru Horikoshi, Hiroji Iwata, Sadamoto Zenda, Tsuguo Iwatani, Asao Ogawa, Akira Inoue, Masakazu Abe, Tatsuya Toyama, Yosuke Uchitomi, Hiromichi Matsuoka, Hisashi Noma, Tatsuo Akechi
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-13 (2023)
Abstract Background Cancer patients experience various forms of psychological distress. Their distress, mainly in the form of depression and anxiety, leads to poor quality of life, increased medical spending due to frequent visits, and decrease in tr
Externí odkaz:
https://doaj.org/article/10dc5dd418f4482884298f56b4e8da0d
Autor:
Kayono Onishi, Rurina Watanuki, Takamichi Yokoe, Tsuguo Iwatani, Chisako Yamauchi, Tatsuya Onishi
Publikováno v:
Case Reports in Oncology, Vol 15, Iss 2, Pp 738-744 (2022)
We present a case of two recurrences in the brachial lymph nodes after initial resection, which was performed for radical cure. A 66-year-old woman was diagnosed with left breast cancer T4bN3cM0 Stage IIIC and an immunohistochemistry assay showed est
Externí odkaz:
https://doaj.org/article/4c378e9fbd66410196d0475dcee45fd8
Publikováno v:
Current Oncology, Vol 28, Iss 5, Pp 4203-4212 (2021)
We aimed to determine the dynamic trends in health state utility values (HSUVs) in patients with end-stage breast cancer. We selected 181 patients comprising 137 with primary breast cancer (PBC) and 44 with metastatic breast cancer (MBC) (28 survivor
Externí odkaz:
https://doaj.org/article/003f3e0ca7684991b6dcd4206a732124
Autor:
Satoi Nagasawa, Yuta Kuze, Ichiro Maeda, Yasuyuki Kojima, Ai Motoyoshi, Tatsuya Onishi, Tsuguo Iwatani, Takamichi Yokoe, Junki Koike, Motohiro Chosokabe, Manabu Kubota, Hibiki Seino, Ayako Suzuki, Masahide Seki, Katsuya Tsuchihara, Eisuke Inoue, Koichiro Tsugawa, Tomohiko Ohta, Yutaka Suzuki
Publikováno v:
Communications Biology, Vol 4, Iss 1, Pp 1-13 (2021)
Satoi Nagasawa and Yuta Kuze et al. report a multi-omic analysis of ductal carcinoma in situ (DCIS) of the breast, including whole-exome, single-cell, and spatial transcriptome sequencing. They find that for patients under 45 years of age, HER2 ampli
Externí odkaz:
https://doaj.org/article/e426aed0800f44f79e31480b616c2d54
Autor:
Toshinari Yamashita, Norikazu Masuda, Shigehira Saji, Kazuhiro Araki, Yoshinori Ito, Toshimi Takano, Masato Takahashi, Junji Tsurutani, Kei Koizumi, Masahiro Kitada, Yasuyuki Kojima, Yasuaki Sagara, Hiroshi Tada, Tsutomu Iwasa, Takayuki Kadoya, Tsuguo Iwatani, Hiroki Hasegawa, Satoshi Morita, Shinji Ohno
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-9 (2020)
Abstract Background Trastuzumab (Tmab), pertuzumab (Pmab), and taxane has been a standard first-line treatment for recurrent or metastatic human epidermal growth factor (HER2)-positive breast cancer (HER2+ mBC) but has some safety issues due to taxan
Externí odkaz:
https://doaj.org/article/13394829294f4820b6b1ee9b18116f5f
Publikováno v:
BMJ Open, Vol 11, Iss 12 (2021)
Externí odkaz:
https://doaj.org/article/e7fd9f8b50d74d67ab0d4ad9dcba5c96
Autor:
Toshinari Yamashita, Norikazu Masuda, Shigehira Saji, Kazuhiro Araki, Yoshinori Ito, Toshimi Takano, Masato Takahashi, Junji Tsurutani, Kei Koizumi, Masahiro Kitada, Yasuyuki Kojima, Yasuaki Sagara, Hiroshi Tada, Tsutomu Iwasa, Takayuki Kadoya, Tsuguo Iwatani, Hiroki Hasegawa, Satoshi Morita, Shinji Ohno
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-2 (2020)
An amendment to this paper has been published and can be accessed via the original article.
Externí odkaz:
https://doaj.org/article/bd2ab67ee9e74891b60121739b47389a
Autor:
Ryoko Oi, Hirotaka Koizumi, Ichiro Maeda, Akira Noguchi, Shinobu Tatsunami, Tsuguo Iwatani, Hisanori Kawamoto, Koichiro Tsugawa, Masayuki Takagi
Publikováno v:
Breast Cancer: Basic and Clinical Research, Vol 2016, Iss 10, Pp 211-221 (2016)
Externí odkaz:
https://doaj.org/article/67267f8672f0451eb6fdf506aaca76ed
Publikováno v:
Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 54:63-70
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14368b38b3e62fe0b052054164edf20f
https://doi.org/10.3999/jscpt.54.2_63
https://doi.org/10.3999/jscpt.54.2_63